Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.
Company address
207, Saket Nagar, Near Saket Club, Indore, MP, 452018
Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders.
1. Login to the Kuvera app or website and go to Invest section.
2. Select stocks and search for Syncom Formulation (India) Ltd or scroll over to Syncom Formulation (India) Ltd
3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction.
What is the Share Price of Syncom Formulation (India) Ltd?
The share price of Syncom Formulation (India) Ltd stocks is ₹16.34 as on 10/04/2025
What is the Market Cap of Syncom Formulation (India) Ltd?
Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Syncom Formulation (India) Ltd stock is ₹1,536.0 Cr on 10/04/2025.
In which sector / industry does Syncom Formulation (India) Ltd operate?
Syncom Formulation (India) Ltd operates in Healthcare / Drug Manufacturers - Specialty & Generic.
What was the revenue of Syncom Formulation (India) Ltd?
The revenue of Syncom Formulation (India) Ltd as of 2023 was ₹259.2 Cr
What is the PE ratio of Syncom Formulation (India) Ltd?
The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its
current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is
overvalued in relation to the earnings (revenue) generated. P/E ratio of Syncom Formulation (India) Ltd is
38.06 as on 10/04/2025.
What is the 52 week high price of Syncom Formulation (India) Ltd?
The 52 week high of Syncom Formulation (India) Ltd stock is ₹27.94.
What is the 52 week low price of Syncom Formulation (India) Ltd?
The 52 week low of Syncom Formulation (India) Ltd stock is ₹11.00.
Can fractional shares of Syncom Formulation (India) Ltd be purchased?
No, you cannot buy fractional shares of Syncom Formulation (India) Ltd, or any listed Indian company as of now.